Dr. Gordon McMurray is Chief Development Officer at Sudo Biosciences. He also serves as an Entrepreneur-in-Residence with Frazier Life Sciences.

He was previously co-founder and Chief Scientific Officer at Outpost Medicine from 2016 to 2020. Prior to Outpost, Gordon held several senior roles across multiple therapeutic areas at Pfizer, leading multiple disciplines, teams and projects across Neuroscience, Pain, Sensory Disorders, Genitourinary and Urology indications. Prior to Pfizer, Gordon was a Lecturer in Pharmacology and a Laboratory Head in the Department of Pharmacology at Oxford University, where he was also a member of the Oxford Continence Group.

Gordon holds a B.Sc. and Ph.D. from Queen’s University Belfast.